Shares of ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shot up 22% on Wednesday . The company traded as high as $26.45 and last traded at $26.45. 1,100 shares were traded during trading, an increase of 38% from the average session volume of 800 shares. The stock had previously closed at $21.68.
ALK-Abelló A/S Trading Up 22.0 %
The company’s 50 day moving average price is $21.71 and its 200 day moving average price is $20.34.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
See Also
- Five stocks we like better than ALK-Abelló A/S
- Trading Stocks: RSI and Why it’s Useful
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- What Are Dividends? Buy the Best Dividend Stocks
- Introduction to Fibonacci Retracement Levels
- What is a Special Dividend?
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
